NICE launches PGD consultation
April 12, 2013 by admin
NICE has launched a consultation of new good practice guidance for patient group directions, with a closing date of 29 April. Only registered stakeholders can comment, so see if your organisation is registered if you would like to be involved.
New medicines awareness service from NICE
March 22, 2013 by admin
NICE is to launch new, personalised medicines awareness services - both daily and weekly - to replace the current offerings from the Medicines and Prescribing Centre. In April, existing subscribers will automatically be transferred.
NICE says it is working with UK Medicines Information (UKMi) to develop the new service and to bring together medicines information into one place, so that it ca be found more easily by prescribers and others with medicines responsibilities.
Clinical Knowledge Summaries are back!
March 22, 2013 by admin
A “new and improved” Clinical Knowledge Summaries (CKS) service has been commissioned by NICE and will be going live early in April, according to the company that provides the service.
Existing content is available now and more information about the new service is expected soon, but it will include up to 10 new primary care topics each year.
NeLM and NICE
March 22, 2013 by admin
There are about to be changes in the way medicines information is provided. From 1 April, evidence now provided by the National electronic Library for Medicines (NeLM) will instead be provided by NHS Evidence, managed by NICE. Once the change has happened, there will be a new medicines awareness service too, to replace the newsletter.
NICE evidence summaries
March 22, 2013 by admin
Recent publications from NICE include some evidence summaries in the unlicensed/off-label series:
- Preventing recurrent hypomagnesaemia: oral magnesium glycerophosphate
- Postural hypotension in adults: midodrine
- Polycystic ovary syndrome: metformin in women not planning pregnancy.
NICE publishes evidence summaries
January 26, 2013 by admin
NICE has published some more of its new ‘evidence summaries’. These are not formal NICE guidance but critical reviews of the available evidence to aid decision making. In the ‘unlicensed/off-label medicines’ series, NICE has recently published evidence summaries for: Sleep disorders in children and young people with attention deficit hyperactivity disorder: melatonin and Chronic anal fissure: 2% topical diltiazem hydrochloride. In the ‘new medicines’ series, it has looked at aclidinium bromide and glycopyrronium bromide for chronic obstructive pulmonary disease and lixisenatide for Type 2 diabetes.
NICE launches local formulary guidance
January 26, 2013 by admin
NICE has launched its good practice guide on developing and updating local formularies, which is aimed at helping organisations ensure that their local formularies are fit for purpose and comply with statutory guidance. There are many potential benefits of local formularies - including improving outcomes by optimising medicines use, improving collaboration between clinicians, supporting prescribers in following the guidance of their regulatory bodies, reducing inappropriate variations in care - but they should not act as barriers to the uptake of NICE-approved medicines.
NICE announced its plan for this guide earlier in 2012, after a Department of Health report made clear that medicines receiving a NICE recommendation should, if clinically appropriate, be included in local formularies within 90 days and that local formulary processes should not be attempting to duplicate NICE assessments.
NICE new evidence summaries and guidance
October 23, 2012 by admin
NICE has published the first of its evidence summaries of unlicensed/off-label medicines, about the use of tranexamic acid to prevent or treat significant hemorrhage after trauma, an off-label use. The publication of evidence summaries for insulin degludec in Type 1 and 2 diabetes is expected later this autumn, under new medicines evidence summaries.
NICE has also just published guidance on Crohn’s disease in adults, children and young people, and on headaches in young people and adults. The headache guidance highlights the importance of correct diagnosis in deciding on the most appropriate treatment and also urges healthcare professionals to consider the possibility of medication overuse headaches, a “vicious cycle”, according to the GP who chaired the development of the guideline.
NICE develops prescribing and medicines information
September 25, 2012 by admin
The NICE website now includes a Medicines and Prescribing Centre, following integration with the National Prescribing Centre. This is a useful resource, bringing together lots of advice and sources of support, in several sections, including:
- Evidence summaries: new medicines - although not formal NICE guidance, these are critical reviews of evidence about certain new medicines, to allow evidence-based decision-making. Insulin degludec for Type 1 and 2 diabetes will be one of the first new medicines reviewed.
- Evidence summaries: unlicensed/off-label medicines - the first national source of information for professionals and patients about unlicensed and off-label medicines, and when they are safe and effective, again allowing decisions to be made on the basis of the best available evidence.
- Good practice guidance - starting with the development and updating of local formularies, to be published in December.
- Alerts on medicines and prescribing - sign up to receive these, including one on non-medical prescribing news.
Prescribing and medicines management resources now at NICE
June 14, 2012 by admin
The National Prescribing Centre (NPC) is now fully integrated with NICE, as its Medicines and Prescribing Centre. This is where information, advice and news on prescribing and medicines will be published in future including, for the first time, summaries of the evidence for certain unlicensed and off-label medicines.
Categories
Recent Posts
- Pharmacists and chronic pain prescribing: first RCT
- Comparing nurse prescribing and PGD use in a UK emergency department
- Antibiotics for lower back pain study hits headlines
- PGD good practice guidance expected in June
- Latest NICE guidance and evidence summaries
- NICE launches PGD consultation
- New medicines awareness service from NICE
- Clinical Knowledge Summaries are back!
- Should professional indemnity insurance be compulsory?
- GMC issues updated prescribing guidance
Tags
- ANP conference Carey N CD children CKS Clinical Knowledge Summaries consultation controlled drugs COPD Courtenay Courtenay M CPD dermatology DH diabetes generic substitution GMC Home Office Matt Griffiths mental health MeReC MHRA Misuse of Drugs mixing medicines National Prescribing Centre NICE NMC non-medical prescribing NPC NPF NPSA Nurse prescribing off-label Patient Group Directions PGD PGDs physiotherapist podiatrist Prescribing Prescribing errors RCN Scotland Stenner K supplementary prescribers unlicensed medicines
